| Literature DB >> 19295482 |
Mie Shimizu1, Naoki Hasegawa, Tomoyasu Nishimura, Yoshihiko Endo, Yoshiki Shiraishi, Wakako Yamasawa, Hidefumi Koh, Sadatomo Tasaka, Hisato Shimada, Yasushi Nakano, Seitaro Fujishima, Kazuhiro Yamaguchi, Akitoshi Ishizaka.
Abstract
We studied the effects of TNF-converting enzyme inhibition with Y-41654, which down-regulates the production of soluble TNF-alpha (sTNF-alpha), on acute lung injury induced by intratracheal administration of LPS. We first verified in vitro that pretreatment of isolated alveolar macrophages from Sprague-Dawley male rats with 20 microL of 0.1-mM Y-41654, decreased significantly (P < 0.05) the concentration of sTNF-alpha in cell supernatants induced by 10 microg/mL of LPS. We then studied four groups of rats (each n = 10) including 1) a control group, 2) an LPS group (300 microg /kg, instilled intratracheally), 3) a Y-41654 group, and 4) a treatment group treated with Y-41654 after LPS instillation. Y-41654, 10 mg/kg in 0.7 mL of phosphate-buffered saline, was administered (i.v.), 15 min before and 0.5, 1.5, 2.5, and 3.5 h after saline or LPS instillation. The animals were observed for 4 h. In the animals treated with Y-41654, the concentrations of sTNF-alpha and protein in bronchoalveolar lavage fluid, and the number of neutrophils in lung tissue and bronchoalveolar lavage fluid were significantly lower at 4 h than in the LPS group (P < 0.05). In conclusion, sTNF-alpha plays an important role in the development of acute lung injury induced by intratracheal administration of LPS, in part modulating neutrophil kinetics.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19295482 DOI: 10.1097/SHK.0b013e3181a2adb7
Source DB: PubMed Journal: Shock ISSN: 1073-2322 Impact factor: 3.454